GSK in talks to buy cancer drugmaker Nuvalent for over $9 bln, FT reports

Markets Investing.com By Investing.com 09 Jun 2026 01:55 1 min read

GSK in talks to buy cancer drugmaker Nuvalent for over $9 bln, FT reports

GSK in talks to buy cancer drugmaker Nuvalent for over $9 bln, FT reports

GSK in talks to buy cancer drugmaker Nuvalent for over $9 bln, FT reports

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.